DarioHealth Corp. (DRIO)

NCM – Цена в реальном времени. Валюта: USD

7.46

-0.21 (-2.74%)

Рынок открыт: Aug 12, 2026, 3:00 PM EDT

7.67

0.00 (0.00%)

Предыдущая сессия: Aug 11, 2026, 7:34 PM EDT

11.08.2026

DarioHealth Corp. (DRIO) Q2 2026 Earnings Call Transcript

11.08.2026

DarioHealth Q2 Earnings Call Highlights

DarioHealth NASDAQ: DRIO reported second-quarter 2026 revenue of $5.2 million, down from $5.6 million in the first quarter and $5.4 million a year earlier, as the company continued to shift away from pharmaceutical services revenue toward recurring B2B2C business.

11.08.2026

DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates

DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.76. This compares to a loss of $2.4 per share a year ago.

11.08.2026

DarioHealth Reports Second Quarter 2026 Financial Results

Second quarter 2026 revenue was $5.2 million, reflecting the Company's strategic decision to discontinue certain pharmaceutical-related business Gross margin increased to 62%, compared to 57% in the first quarter of 2026 and 55% in the second quarter of 2025; non-GAAP B2B2C gross margin was approximately 80% for the 10th consecutive quarter Operating loss decreased by 30% year-over-year and 11% quarter-over-quarter Operating expenses declined by 21% year-over-year and 8% quarter-over-quarter Multi-condition strategy compounding: more than 80% of the $13.1 million in contracted and late-stage annual recurring revenue ("ARR") is multi-condition Commercial momentum with three significant wins in recent weeks, led by a top-5 national health plan expansion with the potential to approximately triple Dario's potential revenue opportunity — its third such expansion — plus a 5th Fortune 50 client and a new health insurer via the Amwell channel Expanded into provider-backed clinical care delivery, accessing a larger portion of the healthcare value chain and increasing the potential revenue opportunity per client Pro forma cash of $36.8 million following $22.8 million net proceeds from at-the-market registered direct financing with participation from existing long-term shareholders and new fundamental institutional investors completed in July 2026 Conference call today, August 11, 2026 at 8:30 am ET NEW YORK, Aug. 11, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced financial results for the second quarter ended June 30, 2026. "We believe that Dario has reached an important stage where the investments made in our technology, product, and distribution infrastructure are compounding positive momentum," said Erez Raphael, Chief Executive Officer of Dario.

04.08.2026

Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand

New programs, expected to begin revenue contribution Q4 2026, extend Dario's integrated healthcare platform into two high-impact clinical categories while advancing execution of the Company's provider-backed care strategy AI-enabled programs combine digital engagement, human behavioral coaching and clinical care to improve outcomes while expanding Dario's participation in reimbursement-driven healthcare services NEW YORK, Aug. 4, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced it has further expanded its provider-backed cardiometabolic platform with the launch of Dario Women™ and Dario Sleep™. The two new programs address important drivers of cardiometabolic health through an integrated care experience combining AI-powered engagement, behavioral support and access to licensed healthcare providers.

03.08.2026

DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026

Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK, Aug. 3, 2026 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leading artificial intelligence ("AI")-powered healthcare technology company transforming the management of chronic conditions, announced today that it will release its financial results for the 2nd quarter ended June 30th, 2026 and will host a conference call and webcast at 8:30 a.m.

Видео

No Data

There is no data to display

Пресс-релизы

11.08.2026

DarioHealth Corp. (DRIO)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

DarioHealth Corp. (DRIO)

DarioHealth Corp. (DRIO) Q2 2026 Earnings Call Transcript

DarioHealth Q2 Earnings Call Highlights

DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates

DarioHealth Reports Second Quarter 2026 Financial Results

Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand

DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026

Видео

No Data

Пресс-релизы

DarioHealth Reports Second Quarter 2026 Financial Results

DarioHealth Corp. (DRIO) Q2 2026 Earnings Call Transcript

DarioHealth Q2 Earnings Call Highlights

DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates

DarioHealth Reports Second Quarter 2026 Financial Results

Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand

DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026

Видео

No Data

Пресс-релизы

DarioHealth Reports Second Quarter 2026 Financial Results

Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand

Search stocks

DarioHealth Corp. (DRIO)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

DarioHealth Corp. (DRIO)

DarioHealth Corp. (DRIO) Q2 2026 Earnings Call Transcript

DarioHealth Q2 Earnings Call Highlights

DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates

DarioHealth Reports Second Quarter 2026 Financial Results

Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand

DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026

Видео

No Data

Пресс-релизы

DarioHealth Reports Second Quarter 2026 Financial Results

DarioHealth Corp. (DRIO) Q2 2026 Earnings Call Transcript

DarioHealth Q2 Earnings Call Highlights

DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates

DarioHealth Reports Second Quarter 2026 Financial Results

Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand

DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026

Видео

No Data

Пресс-релизы

DarioHealth Reports Second Quarter 2026 Financial Results

Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand